Category: Research & Development
North America Research & Development
-
Somatropin Market, by Dosage Form (Powder, Solvent), by Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Somatropin injection is used to replace growth hormone (a natural ... Read More
-
Primary Sclerosing Cholangitis Market, by Drug (BT1023, GS-9674, NGM282, OCA, LUM001, DUR928, norUDCA, HTD1801, IDN-7314, STP705) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Opportunity Analysis, 2022 - 2030 Primary sclerosing cholangitis (PSC) is generally a progressive disease that eventually culminates in cirrhosis with complications (portal hypertension, end-stage liver disease, and hepatic failure). Bile ducts carry the digestive liquid ... Read More
-
North America Glucagon-Like Peptide-1 (GLP-1) Agonists Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... during the forecast period 2022-2027. The COVID-19 pandemic positively impacted a few segments of the North American Glucagon-like Peptide-1 (GLP-1) Agonists Market. Diabetes and uncontrolled hyperglycemia are risk factors for poor outcomes in patients with ... Read More
-
Regulatory Intelligence Report for Pharmaceuticals in the U.S.
... comprehensive procedure for the registration, renewal, or notification of the pharmaceuticals, along with the information on the timeline and fee required. The report also focuses on the labeling and advertising regulations for the pharmaceutical and ... Read More
-
US Cannabis State Profiles
... of development. In the continuing absence of federal regulation, market value will continue to be a function of tapering growth maturing states and more recently legalised, emerging markets. Euromonitor International’s US Cannabis State Profiles Global ... Read More
-
Plunkett's Health Care Industry Almanac 2023: Health Care Industry Market Research, Statistics, Trends and Leading Companies
... help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and metrics Industry employment numbers ... Read More
-
North America Analytical Instrumentation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... CAGR of 6.96% during the forecast period 2022-2027. The rising concerns regarding product quality, increasing investments in R&D, and stringent government regulations are some major factors driving the growth of the North American analytical instrumentation ... Read More
-
U.S. Cannabis Testing Market Size By Technology (Chromatography {Liquid Chromatography, Gas Chromatography}, Spectroscopy {Mass Spectrometry, Atomic Spectroscopy}), By Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing), Industry Analysis Report, Zonal Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030
... Analysis Report, Zonal Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030 The U.S. cannabis testing market is expected to garner a significant revenue share by 2030 owing to regulatory requirements ... Read More
-
Scientific Research and Development (R&D) in Telecommunications, Computers, Physical Sciences, Medical Devices and Pharmaceuticals Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 541700
... numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) in Telecommunications, Computers, Physical Sciences, Medical Devices and Pharmaceuticals Industry (U.S.) to reach $205,220,128,592 million by ... Read More
-
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 541711
... numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.) to reach $51,920,726,683 million by ... Read More
-
Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe and RoW) - Global Forecast to 2027
... to 2027 The global cannabis market size is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms ... Read More
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
Cannabis Beverage Market, by Product Type (Alcoholic (Beer, Spirits and Wine) and Non-alcoholic (Marijuana Tea, Cannabis Soda, and Cannabis Coffee & Cold brew)), by End-Use (Household, and Restaurants & Cafes), by Distribution Channel (Convenience stores, Hypermarkets, Specialty, and Online Retail), and by Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Hypermarkets, Specialty, and Online Retail), and by Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Cannabis is psychoactive drug derived from ... Read More
-
North America and South & Central America Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Regions
... Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Regions The North America and South & Central America medical marijuana market was valued at US$ 6,645.16 million in 2021 and ... Read More
-
Medicinal Cannabis Market, by Point of Sale (Dispensaries, Online Pharmacy, Hospital Pharmacy), by Active Ingredient (Tetrahydrocannabinol (THC) and Cannabidiol (CBD)), and by Therapeutic Application (Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), & Other Applications) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... & Other Applications) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Medicinal cannabis, also known as medical marijuana, is used ... Read More
-
Contract Pharmaceutical Manufacturing Market, by Service Type (Contract Manufacturing Organization (CMO) (API Manufacturing, Final Dosage Form Manufacturing, and Packaging), Contract Research Organization (CRO) (Drug Discovery, Preclinical Studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development)), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development)), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, ... Read More
-
Global Axial Spondyloarthritis Market, By Commercialized Therapies (Anti-Tumour Necrosis Factor Therapy(TNF),Anti-Interleukin Therapy(IL), Anti-Janus Kinase Therapy(JAK)); By Potential Pipeline Products (Anti-Janus Kinase Therapy(JAK), Anti-Interleukin (IL)-17 Therapy, Other) ;By Indication(Ankylosing Spondylitis, Non-Radiographic Axial Spondylitis); By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028.
... America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028. Global Axial Spondyloarthritis Market to Reach USD 4.95 Billion by 2028 The growth of the ... Read More
-
Cannabis Extract Market, by Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol), by Product Type (Oil, Shatter, Wax, Hash, Others (Gummies, Cream, etc.)), by Extract Type (Full Spectrum, Broad Spectrum, Isolates), by Indication (Muscle Disorder (Dystonia), Neurological Disorder (Parkinson Disease), Pain Management, Recreational Use), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Disorder (Dystonia), Neurological Disorder (Parkinson Disease), Pain Management, Recreational Use), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, ... Read More
-
Cannabis Testing Services Market, by Test Type (Potency Testing, Terpene Profiling, Cannabinoid Profiling [CBD Testing and THC Testing], Pesticide Screening, Residual Solvent Testing, Microbiological Screening, and Other Tests), by Product Type (Instruments [Chromatography Instruments {Liquid Chromatography, Gas Chromatography, and Others}, Spectroscopy Instruments {Mass Spectroscopy and Atomic Spectroscopy}, Other Instruments], and Consumables & Test Kits), by End Users (Testing Laboratories, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Chromatography, Gas Chromatography, and Others}, Spectroscopy Instruments {Mass Spectroscopy and Atomic Spectroscopy}, Other Instruments], and Consumables & Test Kits), by End Users (Testing Laboratories, Research Institutes, and Others), and by Region (North America, Latin America, ... Read More
-
U.S. Cannabis Market Size, Share & Trends Analysis Report By End-use (Medical, Recreational, Industrial), By Source (Marijuana, Hemp), By Derivative (CBD, THC), And Segment Forecasts, 2022 - 2030
... according to a new report by Grand View Research, Inc. The Growing popularity of vaginal rejuvenation surgery due to the risi Please note The report will be delivered in 2-3 business days upon order notification. Read More
-
United States Human Vaccines Market Size, Share, Top 45 Human Vaccines Brand In-depth Analysis, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast 2022 – 2028
... market is poised to grow by US$ 31,517 million by 2028, accelerating at a CAGR of 7% during the forecast period. The prominent factors that are expected to contribute to the growth of the United ... Read More
-
Cannabis Cultivation Market, by Type (Cannabis Indica and Cannabis Sativa), by Source (Flower/Buds, Leaves, and Others), by Application (Medical Consumption, Recreational Consumption, and Industrial Consumption), and by Region (North America, Latin Americ
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cannabis is the most interesting and rewarding plant to grow as it has a remarkably short lifespan. Cannabis produces chemical compounds, ... Read More
-
US Cannabis Testing Services Market, by Test Type (Potency Testing, Terpene Profiling, Cannabinoid Profiling, (CBD Testing and THC Testing) Pesticide Screening, Residual Solvent Testing, Microbiological Screening and Other Tests), by End User (Cannabis Fi
... Settings, and Research Institutes), and by States (Florida, Michigan, Pennsylvania, New Jersey, New York, and Other States) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 US Cannabis market is highly influenced by rigorous ... Read More
-
North America CBD Gummies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Category (Sugar-Free and Conventional) and Distribution Channel (Specialty Stores, Online Retail, and Others)
... expected to grow from US$ 1,984.1 million in 2021 to US$ 11,147.9 million by 2028; it is estimated to grow at a CAGR of 28.0% from 2021 to 2028. The popularity of CBD is increasing ... Read More
-
North America Minor Cannabinoids Market Databank
... 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid ... Read More
Research Assistance
